Aspirin related gastrointestinal bleeders have an exaggerated bleeding time response due to aspirin use

Gut

Volumn 39, Issue 5, 1996, Pages 654-660

  Lanas, A I ^a   Arroyo, M T ^a   Esteva, F ^a   Cornudella, R ^a   Hirschowitz, B I ^b   Sainz R ^a  

^a HOSPITAL CLÍNICO UNIVERSITARIO LOZANO BLESA   (Spain)

^b University of Alabama   (United States)

Author keywords

Aspirin; Gastrointestinal bleeding; NSAIDs; Platelet; Skin bleeding time; von Willebrand factor

Indexed keywords

ACETYLSALICYLIC ACID; BLOOD CLOTTING FACTOR 8; NONSTEROID ANTIINFLAMMATORY AGENT; VON WILLEBRAND FACTOR;

ADULT; AGED; ARTICLE; BLEEDING TIME; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG METABOLISM; FEMALE; GASTROINTESTINAL HEMORRHAGE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR;

EID: 0030452148     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.39.5.654     Document Type: Article

References (33)

1. Lanas A, Sekar MC, Hirschowitz BI. Objective evidence of aspirin use in both ulcer and non-ulcer upper and lower gastrointestinal bleeding. Gastroenterology 1992; 103: 862-9.
2. Langman MJS, Weil J, Wainwright P, Lawson DH, Rawlins XX, Logan RFA, et al. Risks of bleeding peptic ulcer associated with individual non-steroidal anti-inflammatory drugs. Lancet 1994; 343: 1075-8.
3. Faulkner G, Prichard P, Somerville K, Langman MJ. Aspirin and bleeding peptic ulcers in the elderly. BMJ 1988; 297: 1311-3.
4. McCarthy DM. Nonsteroidal anti-inflammatory drugs - the clinical dilemmas. Scand J Gastroenterol 1992; 27 (suppl 192): 9-16.
5. Day JP, Lanas A, Rustagui P, Hirschowitz BI. Reversible prolonged skin bleeding time due to aspirin, found in acute GI bleeders but not in controls. J Clin Gastroenterol 1996; 22: 96-103.
6. Fiore LD, Brophy MT, Lopez A, Janson P, Deykin D. The bleeding time response due to aspirin. Identifying the hyperresponder. Am J Clin Pathol 1990; 94: 292-6.
7. Stuart MJ, Miller ML, Davey FR, Wolk JA. The post aspirin bleeding time: a screening test for evaluating hemostatic disorders. Br J Haematol 1979; 43: 649-59.
8. Smith C. Surgicutt: A device for modified template bleeding times. J Med Tech 1986; 3: 229-31.
9. Mielke Ch, Kaneskiro MM, Maher Y, Weiner JM, Rapaport SI. The standardized normal Ivy bleeding time and its prolongation by aspirin. Blood 1969; 34: 204-15.
10. Deykin D, Janson P, McMaron L. Ethanol potentiation of aspirin-induced prolongation of the bleeding time. N Engl J Med 1982; 8: 852-4.
11. Bakar SK, Niazi S. High-performance liquid chromatographic determination of aspirin and its metabolites in plasma and urine. J Pharm Sci 1983; 27: 1020-3.
12. Connor AM, Laposata M. A rapid assay for platelet thromboxane production and its use assessing prior aspirin ingestion. Am J Clin Pathol 1988; 89: 216-21.
13. Mieuwenhuis K, Akkerman JWN, Sixma JJ. Patients with a prolonged bleeding time and normal aggregation test may have storage pool deficiency: studies on one hundred and six patients. Blood 1987; 78: 620-3.
14. Henry D, Dobson A, Turner C. Variability in the risk of major gastrointestinal complications from nonaspirin nonsteroidal anti-inflammatory drugs. Gastroenterology 1993; 105: 107-8.
15. Willard JE, Lange RA, Hillis DL. The use of aspirin in ischemic heart disease. N Engl J Med 1992; 327: 175-81.
16. Kurata JH, Abbey DE. The effect of chronic aspirin use on duodenal and gastric ulcer hospitalizations. J Clin Gastroenterol 1990; 12: 260-6.
17. Nyman I, Larsson H, Wallentin L. Prevention of serious cardiac events by low-dose aspirin in patients with silent myocardial ischaemia. Lancet 1992; 340: 497-501.
18. The Dutch TIA Study Group. A comparison of two doses of aspirin (30 mg vs. 283 mg a day) in patients after a transient ischemic attack or minor ischemics stroke. N Engl J Med 1991; 325: 12261-6.
19. Silagy CA, McNeil JJ, Donnan GA, Tonkin AM, Worsan B, Campion K. Adverse effects of low-dose aspirin in a healthy elderly population. Clin Pharmacol Ther 1993; 54: 84-9.
20. Langman MJS. Ulcer complications and nonsteroidal antiinflammatory drugs. Am J Med 1988; 84: 15-9.
21. Bang CJ, Riedel B, Talstad Y, Berstad A. Interaction between heparin and acetylsalicylic acid on gastric mucosal and skin bleeding in humans. Scand J Gastroenterol 1992; 27: 489-94.
22. Gaspari F, Vigano G, Orisio S, Bonati M, Livio M, Remuzzi G. Aspirin prolongs bleeding time in uremia by a mechanism distinct from platelet cyclooxygenanase inhibition. J Clin Invest 1987; 79: 1788-97.
23. Hirsch J, Street D, Cade JF, Amy H. Relation between bleeding time and platelet connective tissue reaction after aspirin. Blood 1973; 41: 369-77.
24. Stuart MJ, Miller ML, Davey FR, Wolk JA. The post aspirin bleeding time: a screening test for evaluating hemostatic disorders. Br J Haematol 1979; 43: 649-59.
25. Buchanan GR, Holkamp CA. A comparative study of variables affecting the bleeding time using two disposable devices. Am J Clin Pathol 1989; 91: 45-51.
26. Barber A, Green D, Galluzo T, Tsao CH. The bleeding time as a preoperative screening test. Am J Med 1985; 78: 761-4.
27. Bick R, Adams T, Schmalhorst W. Bleeding times, platelet adhesion and aspirin. Am J Clin Pathol 1976; 65: 69-72.
28. Kumar R, Ansell SE, Canoso RT, Deykin D. Clinical trial of new bleeding time device. Am J Clin Pathol 1978; 70: 642-5.
29. Daneshmend TK, Sharma HK, Hawthorne AB, Bhaakar NK, Hawkey CJ. A new measure, the gastric bleeding time prolongation by aspirin in human. Gastroenterology 1989; 96: 108A.
30. O'Laughlin J, Hoftiezer J, Mahoney J, Ivey K. Does aspirin prolong bleeding from gastric biopsies in man? Gastrointest Endosc 1981; 27: 1-5.
31. Allison MC, Fullarton GM, Brown IL, Crean GP, McColl KEL. Enhanced gastric mucosal haemostasis after upper gastrointestinal haemorrhage. Gut 1991; 32: 735-9.
32. Whittle BJR, Kauffman GL Jr, Moncada S. Hemostatic mechanisms independent of platelet aggregation arrest gastric mucosal bleeding. Proc Natl Acad Sci USA 1986; 83: 5683-7.
33. Sherine E, Gabriel MD, Kkmainer LJ, Bombadier C. Risk for serious gastrointestinal complications related to use of nonsteroidal antiinflammatory drugs. Ann Intern Med 1991; 115: 787-96.